Jonathan Eckard analyst

Currently out of the existing stock ratings of Jonathan Eckard, 16 are a BUY (76.19%), 5 are a HOLD (23.81%).

Jonathan Eckard

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Eckard, currently employed carries an average stock price target met ratio of 61.9% that have a potential upside of 31.39% achieved within 525 days. Previously, Jonathan Eckard worked at BARCLAYS.

Jonathan Eckard’s has documented 34 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ALKS, Alkermes Plc at 29-Jul-2016.

Wall Street Analyst Jonathan Eckard

Analyst best performing recommendations are on ALKS (ALKERMES PLC).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 10/7/2015. The price target of $79 was fulfilled within 78 days with a profit of $19.02 (31.71%) receiving and performance score of 4.07.

Average potential price target upside

ICPT Intercept Pharmaceuticals ALKS Alkermes Plc AMRN Amarin PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$19

$19

1 years 2 months 28 days ago
(27-Sep-2023)

10/13 (76.92%)

$0.42 (2.26%)

63

Hold

$19

$12

1 years 2 months 28 days ago
(27-Sep-2023)

4/7 (57.14%)

$0.42 (2.26%)

111

Hold

$19

$13

1 years 2 months 28 days ago
(27-Sep-2023)

12/25 (48%)

$0.42 (2.26%)

39

Hold

$19

$20

1 years 2 months 28 days ago
(27-Sep-2023)

3/8 (37.5%)

$0.42 (2.26%)

63

Hold

$19

$15

1 years 2 months 28 days ago
(27-Sep-2023)

3/13 (23.08%)

$0.42 (2.26%)

57

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jonathan Eckard?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?